| Sep 11 |
Despite Fast-paced Momentum, Precision BioSciences (DTIL) Is Still a Bargain Stock
|
| Sep 4 |
Precision BioSciences to Participate in Upcoming H.C. Wainwright 26th Annual Global Healthcare Conference
|
| Sep 3 |
Precision BioSciences Receives $13 Million in Proceeds from Imugene Convertible Note Maturity as Part of the August 2023 Azer-cel Deal
|
| Aug 28 |
Wall Street Analysts Believe Precision BioSciences (DTIL) Could Rally 307.93%: Here's is How to Trade
|
| Aug 12 |
FDA grants IND clearance for TG Therapeutics’ trial of multiple sclerosis treatment
|
| Aug 9 |
Precision BioSciences Announces Investigational New Drug Clearance by Partner TG Therapeutics for Investigation of Azer-Cel for Multiple Sclerosis
|
| Aug 1 |
Precision BioSciences (DTIL) Tops Q2 Earnings and Revenue Estimates
|
| Aug 1 |
Precision BioSciences GAAP EPS of $4.70 beats by $6.32, revenue of $49.9M beats by $41.58M
|
| Aug 1 |
Precision BioSciences: Q2 Earnings Snapshot
|
| Aug 1 |
Precision BioSciences Reports Second Quarter 2024 Financial Results and Provides Business Update
|
